---
document_datetime: 2024-03-21 09:21:59
document_pages: 2
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/neparvis-epar-all-authorised-presentations_en.pdf
document_name: neparvis-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 2.5190033
conversion_datetime: 2025-12-17 09:49:55.931034
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.1-arm64-arm-64bit-Mach-O
---
| MA (EU) number   | (Invented) name   | Strength     | Pharmaceutical Form             | Route of Administration   | Immediate Packaging   | Pack size                        |
|------------------|-------------------|--------------|---------------------------------|---------------------------|-----------------------|----------------------------------|
| EU/1/16/1103/001 | Neparvis          | 24 mg/26 mg  | Film-coated tablet              | Oral use                  | Blister (PVC/PVDC)    | 28 tablets                       |
| EU/1/16/1103/002 | Neparvis          | 49 mg/51 mg  | Film-coated tablet              | Oral use                  | Blister (PVC/ PVDC)   | 28 tablets                       |
| EU/1/16/1103/003 | Neparvis          | 49 mg/51 mg  | Film-coated tablet              | Oral use                  | Blister (PVC/ PVDC)   | 56 tablets                       |
| EU/1/16/1103/004 | Neparvis          | 49 mg/51 mg  | Film-coated tablet              | Oral use                  | Blister (PVC/ PVDC)   | 168 (3 x 56) tablets (multipack) |
| EU/1/16/1103/005 | Neparvis          | 97 mg/103 mg | Film-coated tablet              | Oral use                  | Blister (PVC/ PVDC)   | 28 tablets                       |
| EU/1/16/1103/006 | Neparvis          | 97 mg/103 mg | Film-coated tablet              | Oral use                  | Blister (PVC/ PVDC)   | 56 tablets                       |
| EU/1/16/1103/007 | Neparvis          | 97 mg/103 mg | Film-coated tablet              | Oral use                  | Blister (PVC/ PVDC)   | 168 (3 x 56) tablets (multipack) |
| EU/1/16/1103/008 | Neparvis          | 24 mg/26 mg  | Film-coated tablet              | Oral use                  | Blister (PVC/PVDC)    | 14 tablets                       |
| EU/1/16/1103/009 | Neparvis          | 24 mg/26 mg  | Film-coated tablet              | Oral use                  | Blister (PVC/PVDC)    | 20 tablets                       |
| EU/1/16/1103/010 | Neparvis          | 24 mg/26 mg  | Film-coated tablet              | Oral use                  | Blister (PVC/PVDC)    | 56 tablets                       |
| EU/1/16/1103/011 | Neparvis          | 49 mg/51 mg  | Film-coated tablet              | Oral use                  | Blister (PVC/PVDC)    | 14 tablets                       |
| EU/1/16/1103/012 | Neparvis          | 49 mg/51 mg  | Film-coated tablet              | Oral use                  | Blister (PVC/PVDC)    | 20 tablets                       |
| EU/1/16/1103/013 | Neparvis          | 49 mg/51 mg  | Film-coated tablet              | Oral use                  | Blister (PVC/PVDC)    | 196 (7 x 28) tablets (multipack) |
| EU/1/16/1103/014 | Neparvis          | 97 mg/103 mg | Film-coated tablet              | Oral use                  | Blister (PVC/PVDC)    | 14 tablets                       |
| EU/1/16/1103/015 | Neparvis          | 97 mg/103 mg | Film-coated tablet              | Oral use                  | Blister (PVC/PVDC)    | 20 tablets                       |
| EU/1/16/1103/016 | Neparvis          | 97 mg/103 mg | Film-coated                     | Oral use                  | Blister (PVC/PVDC)    | 196 (7 x 28) tablets (multipack) |
| EU/1/16/1103/017 | Neparvis          | 24 mg/26 mg  | tablet Film-coated tablet       | Oral use                  | Blister (PVC/PVDC)    | 196 (7 x 28) tablets (multipack) |
| EU/1/16/1103/018 | Neparvis          | 6 mg/6 mg    | Granules in capsule for opening | Oral use                  | blister (PA/alu/PVC)  | 60 capsules                      |

<div style=\"page-break-after: always\"></div>

| EU/1/16/1103/019   | Neparvis   | 15 mg/16 mg   | Granules in capsule for opening   | Oral use   | blister (PA/alu/PVC)   | 10 film-coated granules   | 60 capsules   |
|--------------------|------------|---------------|-----------------------------------|------------|------------------------|---------------------------|---------------|